Literature DB >> 1326261

Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus.

E Argo1, B Gimenez, P Cash.   

Abstract

Infection of rhabdomyosarcoma (RD) cells by coxsackie B5 virus (CBV5) was non-cytopathic, although low titres of infectious virus were produced after 24 h post-infection. The extent of CBV5 replication in RD cells increased after sequential passage of the virus in these cells. The RD cells from the first cycle of CBV5 infection were recovered and maintained in culture for 3 months (equivalent to 21 passages) releasing infectious virus throughout this period; these cells were considered to be persistently infected with CBV5 and were designated piRD cells. Coxsackie virus antigen was demonstrated in a small proportion of piRD cells by immunofluorescence staining. High resolution two-dimensional polyacrylamide gel electrophoresis was used to analyse the intracellular proteins prepared from piRD cells, three proteins were detected which were absent in uninfected RD cells. These new proteins were similar in charge to virus proteins induced during CBV5 lytic infection of HEp-2 cells. Quantitative densitometry of 2-dimensional protein profiles of piRD and uninfected cells showed no significant disruption of RD cell protein synthesis by the persistent virus infection. Three cloned cell lines were recovered from piRD cells, none of which showed evidence of infectious virus or virus-induced protein synthesis suggesting that the parental cell line was a carrier culture for CBV5.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326261     DOI: 10.1007/bf01309696

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  33 in total

1.  Analysis of virus protein heterogeneity among group B coxsackie viruses using a "mini" two-dimensional gel electrophoresis system.

Authors:  P Cash
Journal:  Electrophoresis       Date:  1989-11       Impact factor: 3.535

2.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Detection of heritable mutations as quantitative changes in protein expression.

Authors:  C S Giometti; M A Gemmell; S L Nance; S L Tollaksen; J Taylor
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

4.  Persistence of echovirus 6 in cloned human cells.

Authors:  J P Gibson; V F Righthand
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

5.  A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus.

Authors:  P Cash; W H Wunner; C R Pringle
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

6.  Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4: association of antigenic determinants with myocarditic properties of the virus.

Authors:  Y Cao; D P Schnurr; N J Schmidt
Journal:  J Gen Virol       Date:  1984-05       Impact factor: 3.891

7.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79.

Authors:  M Moore; M H Kaplan; J McPhee; D J Bregman; S W Klein
Journal:  Public Health Rep       Date:  1984 Sep-Oct       Impact factor: 2.792

9.  Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome.

Authors:  J W Gow; W M Behan; G B Clements; C Woodall; M Riding; P O Behan
Journal:  BMJ       Date:  1991-03-23

10.  Insulin mRNA content in pancreatic beta cells of coxsackievirus B4-induced diabetic mice.

Authors:  N K Chatterjee; C Nejman
Journal:  Mol Cell Endocrinol       Date:  1988-02       Impact factor: 4.102

View more
  4 in total

Review 1.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Charlotta Polacek; Jana Precechtelova; Miriam Badurova; Martin Sojka; Camilla Mohlin; Stina Israelsson; Kjell Johansson; Shubhada Bopegamage; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

3.  Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.

Authors:  Paula Turkki; Mira Laajala; Marie Stark; Helena Vandesande; Heidi Sallinen-Dal Maso; Sailee Shroff; Anna Sävneby; Ganna Galitska; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.

Authors:  Anna Sävneby; Johannes Luthman; Fabian Nordenskjöld; Björn Andersson; A Michael Lindberg
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.